Methods for evaluating the ability to metabolize pharmaceuticals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6929912
APP PUB NO 20030096251A1
SERIAL NO

10085612

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for detecting variant genes having a polymorphism associated with reduced metabolism of a substrate selected from the group consisting of a CYP3A4 substrate, a CYP3A5 substrate and a GSTM1 substrate in an individual are disclosed. The methods are genotyping methods to identify specific polymorphisms which have been found to be associated with reduced metabolism of chemotherapeutic agents, such as cyclophosphamide and BCNU. Also disclosed are novel polymorphic nucleic acid molecules useful in the methods of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • DUKE UNIVERSITY;GENAISSANCE PHARMACEUTICALS, INC.;PGXHEALTH, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Colvin, Oliver M Chapel Hill, NC 1 0
Guida, Marco San Diego, CA 11 57
Hall, Jeff Carlsbad, CA 38 498
Marks, Jeffrey R Hillsborough, NC 3 30
Petros, William P Morgantown, WV 1 0
Vredenburgh, James J Chapel Hill, NC 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation